Published in World J Gastroenterol on August 01, 2003
Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol (2009) 1.51
Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ? World J Gastroenterol (2006) 1.35
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol (2004) 1.25
Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad Med J (2006) 1.23
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut (2005) 1.12
Familial aggregation in inflammatory bowel disease: is it genes or environment? World J Gastroenterol (2011) 0.92
RAGE gene three polymorphisms with Crohn's disease susceptibility in Chinese Han population. World J Gastroenterol (2014) 0.85
Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients. World J Gastroenterol (2013) 0.85
1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci (2008) 0.82
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam (2012) 0.79
Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol (2007) 0.77
Association between STAT3 gene polymorphisms and Crohn's disease susceptibility: a case-control study in a Chinese Han population. Diagn Pathol (2014) 0.77
Loss of fragile histidine triad protein expression in inflammatory bowel disease. World J Gastroenterol (2006) 0.75
Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol (2004) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Genetic dissection of complex traits. Science (1994) 29.54
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem (2000) 6.54
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology (2002) 4.20
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20
Activation of nuclear factor kappa B inflammatory bowel disease. Gut (1998) 4.14
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90
Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem (1999) 3.81
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem (2000) 3.23
Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology (2002) 2.71
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology (2002) 2.66
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
Genetic analyses of chromosome 12 loci in Crohn's disease. Gut (2000) 2.30
Anticipation in Crohn's disease may be influenced by gender and ethnicity of the transmitting parent. Am J Gastroenterol (1998) 2.14
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet (2002) 2.12
Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest (2001) 1.96
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet (1996) 1.93
Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology (1989) 1.80
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet (2002) 1.76
A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis (1999) 1.74
CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet (2002) 1.74
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 1.73
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71
Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet (1998) 1.64
IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics (1999) 1.62
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis (2000) 1.60
International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet (2001) 1.58
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med (1992) 1.56
Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis (2000) 1.55
Genetics of inflammatory bowel disease. Isr Med Assoc J (2002) 1.52
High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet (2000) 1.52
Susceptibility loci in inflammatory bowel disease. Lancet (1996) 1.49
The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet (1989) 1.48
Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology (1995) 1.47
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology (2000) 1.40
Genetics of inflammatory bowel disease: a puzzle with contradictions? Gut (2000) 1.39
HLA-DR2 gene and Spanish patients with ulcerative colitis. Rev Esp Enferm Dig (1998) 1.39
Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann Hum Genet (1998) 1.34
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ (1993) 1.34
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology (1998) 1.32
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology (1999) 1.29
Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics (2002) 1.25
Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun (2000) 1.24
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology (2002) 1.21
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology (2002) 1.20
Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology (1995) 1.18
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A (2001) 1.17
Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet (1998) 1.17
HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology (1995) 1.14
Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am J Pathol (2001) 1.11
Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut (1999) 1.09
Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet (2002) 1.08
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. Gastroenterology (2001) 1.05
Inflammatory bowel disease in spouses and their offspring. Gastroenterology (2001) 1.05
Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut (1998) 1.05
Genetic epidemiology in inflammatory bowel disease. Dig Dis (1999) 1.05
CARD15 gene and the classification of Crohn's disease. Immunogenetics (2002) 1.04
The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease. Int J Colorectal Dis (1998) 1.03
Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol (1999) 1.01
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet (2000) 1.01
Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00
Low incidence of ulcerative colitis and proctitis in Bangladeshi migrants in Britain. Digestion (1992) 1.00
Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut (2001) 0.99
HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens (1999) 0.98
Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol (1998) 0.98
Association of HLA class II genes with susceptibility to Crohn's disease. Gut (1996) 0.97
Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet (2001) 0.96
Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics (2001) 0.96
Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese. Tissue Antigens (2001) 0.95
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin Exp Immunol (1997) 0.95
Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol (1992) 0.94
HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut (1996) 0.94
Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populations. Int J Colorectal Dis (2001) 0.90
Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity. Inflamm Bowel Dis (2000) 0.90
Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun (2001) 0.88
Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis (1996) 0.88
The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease. Am J Gastroenterol (2001) 0.88
Smoothened gene mutations found in digestive cancer have no aberrant Hedgehog signaling activity. J Gastroenterol (2007) 0.79
Comprehensive analysis on clinical features of Wilson's disease: an experience over 28 years with 133 cases. Neurol Res (2013) 0.79
Cytokine expression and the role of Th17 cells in a mouse model of colitis. Mol Med Rep (2012) 0.77
Cytokine expression and the role of Thl7 cells in mice colitis. Hepatogastroenterology (2012) 0.76
Retraction notice to candidate agents for pancreatic ductal adenocarcinoma identified by a sub-pathway based method [GENE 540/2 (2014) 232-7]. Gene (2016) 0.75